Why the study?
Does the measurement of biochemical markers improve diagnosis and prediction of functional outcome in patients with acute ischemic stroke?
Does the measurement of biochemical markers improve diagnosis and prediction of functional outcome in patients with acute ischemic stroke?
Biochemical markers of cerebral ischemia and inflammation represent a potential diagnostic and predictive modality in acute ischemic stroke.
Answers are grounded in this paper and cite their sources.
May inform future stroke biomarker strategies; leaves open prospective validation before any clinical adoption.
Biochemical markers of cerebral ischemia and subsequent inflammation represent a potential diagnostic and predictive modality in acute ischemic stroke. Measurement of these markers may improve clinical functions ranging from diagnosis of ischemic stroke to prediction of functional outcome at 3 months. Predictive models, using various biochemical markers, continue to be investigated.
No takes yet. Share an insight, caveat, or question.
Fowler et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: